Soluble expression, purification, and characterization of active recombinant human tissue plasminogen activator by auto-induction in E. coli
Xiaobin Long,Yeran Gou,Miao Luo,Shaocheng Zhang,Hongpeng Zhang,Lei Bai,Shuang Wu,Quan He,Ke Chen,Ailong Huang,Jianzhong Zhou,Deqiang Wang
DOI: https://doi.org/10.1186/s12896-015-0127-y
2015-03-01
BMC Biotechnology
Abstract:BackgroundHuman tissue plasminogen activator (tPA) belongs to the serine protease family. It converts plasminogen into plasmin and is used clinically to treat thrombosis. Human tPA is composed of 527 amino acids residues and contains 17 disulfide bonds. Escherichia coli has been used only rarely for the efficient production of recombinant tPA. However, the functional expression of full-length tPA that contains multiple disulfide bonds on an industrial scale remains challenging. Here, we describe the soluble expression and characterization of full-length tPA by auto-induction in E. coli.ResultsWe achieved optimal levels of gene expression, minimized negative effects related to the production of heterologous proteins, and optimized cytoplasmic yields. Three different E. coli strains, BL21 (DE3), Rosetta, and Origami 2, could express tPA using an auto-induction mechanism. In addition, similar yields of recombinant protein were produced at temperatures of 33, 35, and 37°C. The E. coli strain origami 2 could increase disulfide bond formation in cytoplasmic tPA and produce purified soluble recombinant protein (~0.9 mg/l medium). The full-length tPA was monomeric in solution, and fibrin plate assays confirmed that the recombinant tPA displayed serine protease activity.ConclusionsThis is the first report that describes the heterologous expression of correctly folded active full-length tPA. This could provide valuable information for using prokaryotic auto-induction expression systems to produce tPA at industrial and pharmaceutical levels without in vitro refolding during the production step.
biotechnology & applied microbiology